Coronary artery disease

What changed: Coronary artery disease

Indication page →

Every dated change on the records linked to Coronary artery disease, newest first: approvals and regulatory steps on its medicines, trials that reported, guideline versions, milestones, and when this page itself was checked. Dates come from the records; none is inferred. Orientation, not medical advice.

Approval6Regulatory1This record1

FollowWatch this record and Saved shows what changed since you last looked.Follow by feed

September 2026 · 1

2026-09-22This recordCoronary artery disease
Facts on this page last checked
When this page itself was last checked or edited.

September 2024 · 1

2024-09-27RegulatoryFlurpiridaz F-18
Flurpiridaz F-18: approval (US)
FDA approved Flyrcado (flurpiridaz F 18) injection, NDA 215168, for PET myocardial perfusion imaging under rest or stress (pharmacologic or exercise) in adults with known or suspected CAD.

2024 · 1

2024ApprovalFlurpiridaz F-18
Flurpiridaz F-18 approved in US
PET myocardial perfusion imaging (MPI) under rest or stress (pharmacologic or exercise) in adult patients with known or suspected coronary artery disease, to evaluate for myocardial ischaemia and infarction

2007 · 1

2007ApprovalAmmonia N-13
Ammonia N-13 approved in US
Diagnostic PET imaging of the myocardium under rest or pharmacologic stress to evaluate myocardial perfusion in patients with suspected or existing coronary artery disease

1990 · 1

1990ApprovalTechnetium Tc-99m sestamibi
Technetium Tc-99m sestamibi approved in US
Detecting coronary artery disease by localising myocardial ischaemia and infarction, and evaluating myocardial function

1989 · 1

1989ApprovalRubidium Rb-82 chloride
Rubidium Rb-82 chloride approved in US
PET imaging of the myocardium under rest or pharmacologic stress to evaluate regional myocardial perfusion in adults with suspected or existing coronary artery disease

1977 · 2